The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging
Open accessAbstract
Multifunctional and water-soluble superparamagnetic iron oxide (SPIO) nanocarriers were developed for targeted drug delivery and positron emission tomography/magnetic resonance imaging (PET/MRI) dual-modality imaging of tumors with integrin αvβ3 expression. An anticancer drug was conjugated onto the PEGylated SPIO nanocarriers via pH-sensitive bonds. Tumor targeting ligands, cyclo(Arg-Gly-Asp-D-Phe-Cys) (c(RGDfC)) peptides, and PET 64Cu chelators, macrocyclic 1,4,7-triazacyclononane-N, N′, N″-triacetic acid (NOTA), were conjugated onto the distal ends of the PEG arms. The effectiveness of the SPIO nanocarriers as an MRI contrast agent was evaluated via an in vitro r2 MRI relaxivity measurement. cRGD-conjugated SPIO nanocarriers exhibited a higher level of cellular uptake than cRGD-free ones in vitro. Moreover, cRGD-conjugated SPIO nanocarriers showed a much higher level of tumor accumulation than cRGD-free ones according to noninvasive and quantitative PET imaging, and ex vivo biodistribution studies. Thus, these SPIO nanocarriers demonstrated promising properties for combined targeted anticancer drug delivery and PET/MRI dual-modality imaging of tumors. Keywords: superparamagnetic iron oxide; drug delivery; Positron Emission Tomography (PET); Magnetic Resonance Imaging (MRI); nanomedicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552 · cited 1×
“Many of the pharmacological properties of conventional (“free”) drugs can be improved through the use of drug nanocarriers, including poor solubility in aqueous media, poor biodistribution, unfavorable pharmacokinetics, and lack of selectivity for target tissues [1].”
BackgroundNanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., & Zink, J. I. (2008) · ACS Nano · doi:10.1021/nn800072t · Cited by 1,929
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2006.170 · Cited by 1,436
Self-citationIn vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice
Liu, Z., Cai, W., He, L., Nakayama, N., Chen, K., Sun, X., Chen, X., & Dai, H. (2020) · Nano-Enabled Medical Applications · doi:10.1201/9780429399039-14 · Cited by 1,213
Self-citationMultimodality Imaging Probes: Design and Challenges
Louie, A. (2010) · Chemical Reviews · doi:10.1021/cr9003538 · Cited by 1,044
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Simultaneous PET-MRI: a new approach for functional and morphological imaging
Judenhofer, M. S., Wehrl, H. F., Newport, D. F., Catana, C., Siegel, S. B., Becker, M., Thielscher, A., Kneilling, M., Lichy, M. P., Eichner, M., et al. (2008) · Nature Medicine · doi:10.1038/nm1700 · Cited by 981
Xu, C., Xu, K., Gu, H., Zheng, R., Liu, H., Zhang, X., Guo, Z., & Xu, B. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0464802 · Cited by 887
Nanoplatforms for Targeted Molecular Imaging in Living Subjects
Cai, W., & Chen, X. (2007) · Small · doi:10.1002/smll.200700351 · Cited by 563
Self-citationLee, H.-Y., Li, Z., Chen, K., Hsu, A. R., Xu, C., Xie, J., Sun, S., & Chen, X. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051243 · Cited by 557
Gu, H., Yang, Z., Gao, J., Chang, C. K., & Xu, B. (2005) · Journal of the American Chemical Society · doi:10.1021/ja045220h · Cited by 518
Kim, J., Lee, J. E., Lee, S. H., Yu, J. H., Lee, J. H., Park, T. G., & Hyeon, T. (2008) · Advanced Materials · doi:10.1002/adma.200701726 · Cited by 494
Multimodality Molecular Imaging of Tumor Angiogenesis
Cai, W., & Chen, X. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045922 · Cited by 494
Self-citationPET/NIRF/MRI triple functional iron oxide nanoparticles
Xie, J., Chen, K., Huang, J., Lee, S., Wang, J., Gao, J., Li, X., & Chen, X. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.010 · Cited by 493
Amstad, E., Gillich, T., Bilecka, I., Textor, M., & Reimhult, E. (2009) · Nano Letters · doi:10.1021/nl902212q · Cited by 458
Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature
Cai, W., Chen, K., Li, Z.-B., Gambhir, S. S., & Chen, X. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.043216 · Cited by 429
Self-citationBlodgett, T. M., Meltzer, C. C., & Townsend, D. W. (2007) · Radiology · doi:10.1148/radiol.2422051113 · Cited by 387
Dual-Modality Imaging: Combining Anatomy and Function
Townsend, D. W. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051276 · Cited by 282
PET of vascular endothelial growth factor receptor expression.
Cai, W., Chen, K., Mohamedali, K. A., Cao, Q., Gambhir, S. S., Rosenblum, M. G., & Chen, X. S. (2006) · PubMed · Cited by 262
Self-citationPichler, B. J., Wehrl, H. F., Kolb, A., & Judenhofer, M. S. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.02.001 · Cited by 258
Molecular imaging and therapy of cancer with radiolabeled nanoparticles
Hong, H., Zhang, Y., Sun, J., & Cai, W. (2009) · Nano Today · doi:10.1016/j.nantod.2009.07.001 · Cited by 244
Self-citationEmerging concepts in molecular MRI
Sosnovik, D. E., & Weissleder, R. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.11.001 · Cited by 227
Aryal, S., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Journal of Materials Chemistry · doi:10.1039/b914071a · Cited by 226
Self-citationMultifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging
Yang, X., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Steeber, D. A., & Gong, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.039 · Cited by 217
Self-citationIn Vivo Evaluation of 64Cu-Labeled Magnetic Nanoparticles as a Dual-Modality PET/MR Imaging Agent
Glaus, C., Rossin, R., Welch, M. J., & Bao, G. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900511j · Cited by 211
Xie, J., Xu, C., Xu, Z., Hou, Y., Young, K. L., Wang, S. X., Pourmand, N., & Sun, S. (2006) · Chemistry of Materials · doi:10.1021/cm061793c · Cited by 190
Cai, W., Wu, Y., Chen, K., Cao, Q., Tice, D. A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1480 · Cited by 187
Self-citationPre-clinical PET/MR: technological advances and new perspectives in biomedical research
Wehrl, H. F., Judenhofer, M. S., Wiehr, S., & Pichler, B. J. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1078-0 · Cited by 181
Imaging of Integrins as Biomarkers for Tumor Angiogenesis
Cai, W., Niu, G., & Chen, X. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404308 · Cited by 178
Self-citationBiomimetic Surface Modifications Based on the Cyanobacterial Iron Chelator Anachelin
Zürcher, S., Wäckerlin, D., Bethuel, Y., Mališová, B., Textor, M., Tosatti, S. G. P., & Gademann, K. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056256s · Cited by 142
Dual-modality PET/CT tomography for clinical oncology.
Beyer, T., Townsend, D. W., & Blodgett, T. M. (2002) · PubMed · Cited by 137
Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
Pecorelli, T. A., Dibrell, M. M., Li, Z., Thomas, C. R., & Zink, J. I. (2010) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.841168 · Cited by 84
PET/CT today: System and its impact on cancer diagnosis
Tsukamoto, E., & Ochi, S. (2006) · Annals of Nuclear Medicine · doi:10.1007/bf02984642 · Cited by 68
Napolitano, A., d’Ischia, M., Costantini, C., et al. (1992) · Tetrahedron · doi:10.1016/s0040-4020(01)86599-6 · Cited by 41
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
pH-Sensitive nano-systems for drug delivery in cancer therapy
Liu, J., Huang, Y., Kumar, A., Tan, A., Jin, S., Mozhi, A., & Liang, X.-J. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.009 · Cited by 1,121
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy
Lee, N., Yoo, D., Ling, D., Cho, M. H., Hyeon, T., & Cheon, J. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00112 · Cited by 1,005
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
Arami, H., Khandhar, A., Liggitt, D., & Krishnan, K. M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00541h · Cited by 830
Metadata
- Authors
- Yang, X., Hong, H., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Xiao, Y., Yang, Y., Zhang, Y., Nickles, R. J., Cai, W., Steeber, D. A., & Gong, S.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 32
- Issue
- 17
- Pages
- 4151-4160
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2120766304
- Cited by
- 436
- References
- 37
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.